Target intelligence / Profile preview

Ribosomal protein SA pseudogene 56 (RPSAP56)

Target
RPSAP56
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein SA pseudogene 56 (RPSAP56) is one of multiple pseudogenes related to the functional *RPSA* gene, which encodes a ribosomal protein that also acts as a cell surface laminin receptor[3][5][1]. Pseudogenes like RPSAP56 typically arise from retrotransposition or gene duplication but accumulate mutations that prevent them from encoding a functional protein, and most are considered non-functional "genomic fossils." While some pseudogenes may exert regulatory roles at the RNA level, the specific function of RPSAP56 as an RNA or protein has not been established, and no data indicate that it serves as a disease biomarker, drug target, or protein-coding gene[5]. The only *RPSA* pseudogene in sheep shown to retain an open reading frame is RPSAP7, not RPSAP56[5]. The *RPSA* gene itself, not its pseudogenes, is involved in important cellular processes and disease, including cancer and interaction with pathogenic proteins[1][3]. The target is *not* a receptor, enzyme, transporter, or other therapeutic target. There is something incorrect with the query as a therapeutic target: RPSAP56 is a pseudogene, not a protein or receptor, and thus not druggable or functionally targeted. No roles or interactions relevant to drug development, biomarker discovery, or disease were found for RPSAP56. For anything beyond this (e.g., regulatory RNA roles), there is no supporting evidence for RPSAP56 specifically in humans or disease biology at this time[5].

Other names
RPSA_23_1496RPSAP56
02

Mechanism of action

Not applicable (no known function or drug interaction).

03

Biological functions

None established; as a pseudogene, RPSAP56 is not thought to encode a functional protein or have direct biological functions[5].
04

Disease associations

None established; there is no evidence that RPSAP56 itself is directly involved in disease[5].Note: The functional parent gene, *RPSA*, is involved in cancer and prion diseases, but this does not extend to pseudogenes unless a regulatory function is found[3][5][1].
05

Safety considerations

None reported.
06

Interacting drugs

None reported.
07

Biomarkers

None reported.

Beyond the preview

Go deeper on Ribosomal protein SA pseudogene 56 (RPSAP56).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein SA pseudogene 56 (RPSAP56).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call